BioStrand

company

About

BioStrand is advancing technology for analyzing genetic data, which will drive innovation in the fields of precision medicine.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
€2M
Industries
Bioinformatics,Biotechnology,Genetics,Life Science
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

BioStrand offers a revolutionary methodology for identifying similarities and variations in genetic data and detecting structural anchor points that will drive innovation in precision medicine, drug development and agriculture. The BioStrand methodology enables unprecedented accuracy in detecting similarities and variations in DNA, RNA and proteins. By detecting HYFTSTM, structural 3D information is automatically integrated into the analyses, revolutionising pattern and profile detection that are critical in unraveling diseases and biological processes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2M
BioStrand has raised a total of €2M in funding over 2 rounds. Their latest funding was raised on May 25, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 25, 2020 Seed €2M 1 K & E Detail

Investors

Number of Lead Investors
Number of Investors
1
1
BioStrand is funded by 1 investors. K & E are the most recent investors.
Investor Name Lead Investor Funding Round
K & E Yes Seed